Insider · CIK 0001671111
Carol Webb
Files at CTXR (Citius Pharmaceuticals, Inc.), CTOR (CITIUS ONCOLOGY, INC.). First filing -, latest -.
In brief
Carol Webb files SEC Form 4 as director at CTXR (Citius Pharmaceuticals, Inc.), and also at CTOR (CITIUS ONCOLOGY, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carol Webb has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 300,000 | Dec 22, 2025 |
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 300,000 | Dec 1, 2025 |
| Sep 19, 2025 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Common Stock | +300,000 | $0.00 | $0 | 300,000 | Sep 23, 2025 |
| Dec 12, 2024 | CTOR CITIUS ONCOLOGY, INC. | AGrant or award Stock Option (Right to Buy)derivative | +125,000 | $0.00 | $0 | 125,000 | Dec 16, 2024 |
| Nov 7, 2024 | CTXR Citius Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Purchase Common Stock)derivative | +125,000 | $0.00 | $0 | 125,000 | Nov 12, 2024 |
| Oct 10, 2023 | CTXR Citius Pharmaceuticals, Inc. | AGrant or award Options to Purchase Common Stockderivative | +75,000 | $0.00 | $0 | 75,000 | Oct 12, 2023 |
Questions about Carol Webb
Answered from the filings on this page, as of the latest one.
Is Carol Webb buying or selling?
Carol Webb has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carol Webb's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carol Webb has 0.
Where does Carol Webb file Form 4?
Carol Webb has filed Form 4 at CTXR (Citius Pharmaceuticals, Inc.); CTOR (CITIUS ONCOLOGY, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.